CA1211374A - Compose pharmaceutique contenant plus d'ingredients actifs - Google Patents

Compose pharmaceutique contenant plus d'ingredients actifs

Info

Publication number
CA1211374A
CA1211374A CA000427820A CA427820A CA1211374A CA 1211374 A CA1211374 A CA 1211374A CA 000427820 A CA000427820 A CA 000427820A CA 427820 A CA427820 A CA 427820A CA 1211374 A CA1211374 A CA 1211374A
Authority
CA
Canada
Prior art keywords
weight
cimetidine
ulcer
agent
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000427820A
Other languages
English (en)
Inventor
Eszter Cholnoky
Gyozo Hortobagyi
Elemer Ezer
Laszlo Szporny
Gyorgy Hajos
Judit Matsuz
Mariann Skvorecz
Katalin Pallagi
Eva Palosi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU153682A external-priority patent/HU188167B/hu
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Application granted granted Critical
Publication of CA1211374A publication Critical patent/CA1211374A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA000427820A 1982-05-14 1983-05-10 Compose pharmaceutique contenant plus d'ingredients actifs Expired CA1211374A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HU153582 1982-05-14
HU1536/82 1982-05-14
HU1535/82 1982-05-14
HU153682A HU188167B (en) 1982-05-14 1982-05-14 Process for producing new pharmaceutical compositions against ulcer

Publications (1)

Publication Number Publication Date
CA1211374A true CA1211374A (fr) 1986-09-16

Family

ID=26317386

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000427820A Expired CA1211374A (fr) 1982-05-14 1983-05-10 Compose pharmaceutique contenant plus d'ingredients actifs

Country Status (13)

Country Link
AR (1) AR230570A1 (fr)
AU (1) AU1459183A (fr)
BE (1) BE896711A (fr)
CA (1) CA1211374A (fr)
CH (1) CH655243A5 (fr)
DD (1) DD209735A5 (fr)
DE (1) DE3317578A1 (fr)
DK (1) DK215883D0 (fr)
FI (1) FI831687L (fr)
FR (1) FR2527078B1 (fr)
GB (1) GB2120938B (fr)
NL (1) NL8301722A (fr)
SE (1) SE8302689L (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189788B1 (fr) * 1985-01-23 1989-09-13 ASTA Pharma Aktiengesellschaft Combinaison synergétique de flupirtine et d'anti-phlogistiques non-stéroidaux
US5260333A (en) * 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
AU1252692A (en) * 1991-03-04 1992-10-06 Warner-Lambert Company Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
DK0550083T3 (da) * 1991-12-06 1999-10-11 Glaxo Group Ltd Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra
HU213101B (en) * 1992-12-29 1997-02-28 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition of synergetic gastrocitoprotective activity, containing ranitidine and derivative of the salicylic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU170329B (fr) * 1974-12-12 1977-05-28
US4198402A (en) * 1975-12-17 1980-04-15 Richter Gedeon Vegyeszeti Gyar Rt. Antiphlogistic composition of phenylbutozone and alkali salicylate and method of treatment
US4200631A (en) * 1975-12-17 1980-04-29 Richter Gedeon Vegyeszeti Gyar Rt. Treating mammalian subject sensitive to indomethacin ulcerogenisis
NZ196349A (en) * 1980-03-07 1984-08-24 Interx Research Corp Enhancement of absorption rate of orally administered polar bioactive agents

Also Published As

Publication number Publication date
SE8302689L (sv) 1983-11-15
FR2527078A1 (fr) 1983-11-25
GB8313269D0 (en) 1983-06-22
GB2120938B (en) 1985-09-18
DE3317578A1 (de) 1983-12-01
CH655243A5 (de) 1986-04-15
AU1459183A (en) 1983-11-17
AR230570A1 (es) 1984-05-31
DD209735A5 (de) 1984-05-23
FR2527078B1 (fr) 1987-06-12
NL8301722A (nl) 1983-12-01
FI831687A7 (fi) 1983-11-15
GB2120938A (en) 1983-12-14
BE896711A (fr) 1983-09-01
FI831687L (fi) 1983-11-15
SE8302689D0 (sv) 1983-05-10
DK215883D0 (da) 1983-05-13
FI831687A0 (fi) 1983-05-13

Similar Documents

Publication Publication Date Title
US5238931A (en) Inflammatory bowel disease preventive and curative agent containing zinc l-carnosine salt as active ingredient
JP3305315B2 (ja) 動物及び人間の疼痛及び／又は炎症の抑制時における薬剤ならびにその製造及びその使用
US6017932A (en) Pharmaceutical compositions containing at least one NSAID having increased bioavailability
JP3260378B2 (ja) 腸感染に対する薬物の調製のためのフマギロールおよびその誘導体の使用
ITMI980442A1 (it) Sali nitrati di farmaci antiulcera
IE64285B1 (en) 4-Quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
US4579846A (en) Antiinflammatory compositions and methods
US20260053818A1 (en) Pharmaceutical formulation for the treatment of inflammatory changes to the rectum
FR2527078A1 (fr) Compositions pharmaceutiques anti-ulceres
CN108992456A (zh) 含有香叶木苷硫酸酯衍生物的药物组合物及其应用
JPS6056920A (ja) 脂質レベルの低減方法
US5234927A (en) Solid pharmaceutical composition for oral administration containing dapiprazole
JPH01265027A (ja) 肝疾患治療剤
US3462534A (en) Production of an antidepressant effect with esters of gallic acid
CA2709119C (fr) Agent preventif ou therapeutique destine a traiter l'affection abdominale inflammatoire
CA1177755A (fr) Compose pharmaceutique anti-inflammatoire, anti-pyretique et analgesique
US4470974A (en) Gastric cytoprotection with L-363,586
JP3386873B2 (ja) 消化器系疾患用剤
IL44618A (en) Pharmaceutical compositions comprising mixed salts of polysulfuric esters of naturally occurring glycopeptides with metals and organic bases
JPS6313964B2 (fr)
AU2017384442B2 (en) Oral ibuprofen preparation
KR0129799B1 (ko) 약물중독 치료제 조성물
JPS6149290B2 (fr)
US3833734A (en) P-phenylenediamines as hypolipidemics
GB1565447A (en) Pharmaceutical preparations for venotonic use

Legal Events

Date Code Title Description
MKEX Expiry